Krett NL - Search Results

1

Protein kinase A-independent inhibition of proliferation and induction of apoptosis in human thyroid cancer cells by 8-Cl-adenosine.

Robinson-White AJ, Hsiao HP, Leitner WW, Greene E, Bauer A, Krett NL, Nesterova M, Stratakis CA. Robinson-White AJ, et al. Among authors: krett nl. J Clin Endocrinol Metab. 2008 Mar;93(3):1020-9. doi: 10.1210/jc.2007-2331. Epub 2007 Dec 11. J Clin Endocrinol Metab. 2008. PMID: 18073299 Free PMC article.

2

8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells.

Gandhi V, Ayres M, Halgren RG, Krett NL, Newman RA, Rosen ST. Gandhi V, et al. Among authors: krett nl. Cancer Res. 2001 Jul 15;61(14):5474-9. Cancer Res. 2001. PMID: 11454694

3

Inhibition of ATP synthase by chlorinated adenosine analogue.

Chen LS, Nowak BJ, Ayres ML, Krett NL, Rosen ST, Zhang S, Gandhi V. Chen LS, et al. Among authors: krett nl. Biochem Pharmacol. 2009 Sep 15;78(6):583-91. doi: 10.1016/j.bcp.2009.05.019. Epub 2009 May 27. Biochem Pharmacol. 2009. PMID: 19477165 Free PMC article.

4

8-Amino-adenosine induces loss of phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2, and Akt kinase: role in induction of apoptosis in multiple myeloma.

Ghias K, Ma C, Gandhi V, Platanias LC, Krett NL, Rosen ST. Ghias K, et al. Among authors: krett nl. Mol Cancer Ther. 2005 Apr;4(4):569-77. doi: 10.1158/1535-7163.MCT-04-0303. Mol Cancer Ther. 2005. PMID: 15827330

5

8-Amino-adenosine activates p53-independent cell death of metastatic breast cancers.

Polotskaia A, Hoffman S, Krett NL, Shanmugam M, Rosen ST, Bargonetti J. Polotskaia A, et al. Among authors: krett nl. Mol Cancer Ther. 2012 Nov;11(11):2495-504. doi: 10.1158/1535-7163.MCT-12-0085. Epub 2012 Sep 12. Mol Cancer Ther. 2012. PMID: 22973058 Free PMC article.

6

Regulation of protein kinase C delta by estrogen in the MCF-7 human breast cancer cell line.

Shanmugam M, Krett NL, Maizels ET, Cutler RE Jr, Peters CA, Smith LM, O'Brien ML, Park-Sarge OK, Rosen ST, Hunzicker-Dunn M. Shanmugam M, et al. Among authors: krett nl. Mol Cell Endocrinol. 1999 Feb 25;148(1-2):109-18. doi: 10.1016/s0303-7207(98)00229-9. Mol Cell Endocrinol. 1999. PMID: 10221776

7

The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway.

Querfeld C, Rizvi MA, Kuzel TM, Guitart J, Rademaker A, Sabharwal SS, Krett NL, Rosen ST. Querfeld C, et al. Among authors: krett nl. J Invest Dermatol. 2006 Jul;126(7):1641-7. doi: 10.1038/sj.jid.5700322. Epub 2006 Apr 27. J Invest Dermatol. 2006. PMID: 16645590 Free article.

8

Cyclic adenosine-3',5'-monophosphate-mediated cytotoxicity in steroid sensitive and resistant myeloma.

Krett NL, Zell JL, Halgren RG, Pillay S, Traynor AE, Rosen ST. Krett NL, et al. Clin Cancer Res. 1997 Oct;3(10):1781-7. Clin Cancer Res. 1997. PMID: 9815564

9

Identification of p38β as a therapeutic target for the treatment of Sézary syndrome.

Bliss-Moreau M, Coarfa C, Gunaratne PH, Guitart J, Krett NL, Rosen ST. Bliss-Moreau M, et al. Among authors: krett nl. J Invest Dermatol. 2015 Feb;135(2):599-608. doi: 10.1038/jid.2014.367. Epub 2014 Aug 22. J Invest Dermatol. 2015. PMID: 25148579 Free PMC article.

10

Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines.

Rizvi MA, Ghias K, Davies KM, Ma C, Weinberg F, Munshi HG, Krett NL, Rosen ST. Rizvi MA, et al. Among authors: krett nl. Mol Cancer Ther. 2006 Jul;5(7):1783-9. doi: 10.1158/1535-7163.MCT-05-0465. Mol Cancer Ther. 2006. PMID: 16891464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters